Company Active LTD

Company profile

Closed Loop Medicine Ltd

Homepage - Closed Loop Medicine

Closed Loop Medicine Ltd is a UK company with status active founded in 2017 based in South East England.

CRN
10584642
Founded
2017
Age
9

Overview

Legal name
CLOSED LOOP MEDICINE LTD
Region
South East England
Registered address
1580 PARKWAY, SOLENT BUSINESS PARK
WHITELEY
FAREHAM
HAMPSHIRE
PO15 7AG
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

6 events
31 Mar
2027

Accounts due

Accounts Due

Next accounts due date

08 Feb
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

25 Jan
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Jun
2025

Accounts filed

Accounts

Last accounts made up date

29 Aug
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQzMzgyMTIxN2FkaXF6a2N4

Published 29 Aug 2024 13:55

26 Jan
2017

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2019
Funded years
2019, 2020, 2023
Age at first award
2 years

Projects

2023 Knowledge Transfer Partnership

Queen Mary University of London and Closed Loop Medicine KTP 21-22 R5

2 Feb 2023 to 2 Feb 2025

Awarded
£0
Total cost £0

To exploit novel data analytic approaches to reduce premature death and disability from hypertension. The analysis of data from a customised App and system will safely enable the progressive introduction of automated clinical decision-making, for the precise control of drug dosing.

2020 Feasibility Studies Lead participant

Continuity: Project 105319 - CLOSED LOOP MEDICINE – HYPERTENSION (CLM-HT)

1 Jun 2020 to 31 Mar 2021

Awarded
£250,000
Total cost £250,000

no public description

2020 Feasibility Studies Lead participant

Determination of the link between hypertension and Covid-19

1 Jun 2020 to 31 Mar 2021

Awarded
£47,426
Total cost £47,426

Hypertension (uncontrolled high blood pressure) is the leading preventable cause of premature death worldwide. Globally, 1.39bn people are estimated to have hypertension, and it caused ~10.7 million deaths in 2015\. It is projected to affect more than 1.5 billion people around the world by 2025\. In the UK ~30% of adults have hypertension, 9.5m have a dia...

2019 Collaborative R&D Lead participant

Closed Loop Medicine - Hypertension (CLM-HT)

1 May 2019 to 31 May 2021

Awarded
£663,054
Total cost £1,326,108

"When a clinician treats a patient with a disease, a routine and common approach is to focus on one aspect of the treatment, for example, prescribing a drug. There may then be many weeks or months before review and it may be with a different clinician. It is hard for them to judge whether the first therapy has worked and they may switch to a different the...

Product types

Collaborative R&D Feasibility Studies Knowledge Transfer Partnership